JPRN-UMIN000000828已完成3 期
A Phase III Study Comparing Irinotecan, Cisplatin and Etoposide (PEI) with Nogitecan for the Treatment of Relapsed Small-Cell Lung Cancer (JCOG0605) - A Phase III Study Comparing Irinotecan, Cisplatin and Etoposide (PEI) with Nogitecan for the Treatment of Relapsed Small-Cell Lung Cancer (JCOG0605)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 180 人开始时间: 2007年9月20日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) no active concomitant malignancy 2) pregnancy or lactation 3) serious psychiatric illness 4) steroid treatment 5) massive pleural or pericardial effusion 6) symptomatic brain metastasis 7) interstitial pneumonia or severe pulmonary emphysema 8) diarrhea 9) ileus 10) myocardial infarction within 6 months or unstable angina 11) uncontrollable hypertension 12) uncontrollable diabetes mellitus 13) active infection
研究者
相似试验
已完成
3 期
A Phase III Study Comparing Irinotecan and Cisplatin with Etoposide and Cisplatin for Adjuvant Chemotherapy of Completely Resected Pulmonary High-grade Neuroendocrine Carcinoma (JCOG1205/1206, HGNEC-EP/IP-P3)Pathological stage I-IIIA completely resected pulmonary high-grade neuroendocrine carcinomaJPRN-UMIN000010298Japan Clinical Oncology Group (JCOG)220
招募中
不适用
A phase II study of Irinotecan and cisplatin combination chemotherapy in metastatic, unresectable esophageal cancerNeoplasmsKCT0000670Seoul National University Hospital23
招募中
2 期
Phase II Study of cisplatin plus irinotecan for large cell neuroendocrine carcinomaarge cell neuroendocrine carcinomaJPRN-UMIN000004796ational Cancer Research Center Hospital East44
已完成
不适用
Phase I study of irinotecan and cisplatin with concurrent thoracic radiotherapy in patients with limited-disease small cell lung cancerCancerLung CancerISRCTN75771514Erasmus Medical Centre (The Netherlands)9
已完成
2 期
phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer.extensive disease small-cell lung cancerJPRN-C000000113West Japan Oncology Group45